Related Experiment Video
Updated: Jul 18, 2026

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
Published on: May 23, 2025
Cyclosporin-induced cortical blindness in a patient with dermatomyositis
Takuya Sawabe1, Shinichi Imafuku
1Department of Rheumatology, Hiroshima Red Cross Hospital and Atomic-Bomb Survivors Hospital, 1-9-6 Sendamachi, Naka-ku, Hiroshima 730-8619, Japan. sawabe@bk9.so-net.ne.jp
Abstract:
Cyclosporin A (CsA) has various adverse effects including neurotoxicity. We report the case of a 49-year-old Japanese woman with dermatomyositis who showed CsA-induced cortical blindness. The patient demonstrated cortical blindness despite having a normal blood concentration of CsA. The risk factors of CsA-induced cortical blindness include the use of corticosteroids and vascular injury, which are frequently observed in patients with systemic autoimmune diseases. Clinicians should consider CsA neurotoxicity when using CsA for patients with systemic autoimmune diseases.
Related Concept Videos
Cryptococcal Meningitis
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glaucoma: Overview
Photoreceptors and Visual Pathways
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...